CHI3L1 and Alzheimer disease: However, a recent study regarding the CSF levels of YKL-40 in prodromal AD [17] demonstrated that YKL-40 CSF levels show differences in AD versus MCI patients, implying that this inflammatory marker could predict the conversion of MCI in AD, especially in the presence of APOE ε4 allele.